Related Experiment Video
Updated: Dec 29, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Coping strategies and anxiety in association with methotrexate-induced nausea in juvenile idiopathic arthritis
Nini Kyvsgaard1, Mikael Thastum2, Torben Stamm Mikkelsen3
1Pediatric and Adolescent Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. nini.kyvsgaard@rm.dk.
Insights
Methotrexate-induced nausea in children with juvenile idiopathic arthritis is linked to anxiety and specific coping strategies. Understanding these connections can help manage treatment side effects.
Area of Science:
- Pediatric Rheumatology
- Clinical Psychology
- Pharmacology
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic condition requiring treatment with methotrexate (MTX).
- MTX can cause nausea, impacting treatment adherence and quality of life.
- The role of psychological factors like anxiety and coping strategies in MTX-induced nausea is not fully understood in JIA patients.
Purpose of the Study:
- To investigate the association between methotrexate-induced nausea and anxiety in children with JIA.
- To explore the relationship between MTX-induced nausea and the use of coping strategies in this pediatric population.
- To identify potential psychological mechanisms contributing to variable nausea experiences during MTX therapy.
Main Methods:
- Observational study of 121 children (aged ≥9 years) diagnosed with JIA and treated with MTX.
- Nausea assessed using a nausea diary and the Methotrexate Intolerance Severity Score (MISS).
- Anxiety measured with the Beck Youth Inventories-Anxiety Inventory (BYI-A); coping strategies evaluated with an adapted Nausea Coping Questionnaire.
Main Results:
- MTX-induced nausea was reported by 61% (MISS) to 73% (diary) of children.
- Nausea was significantly associated with higher anxiety scores (BYI-A) and increased use of internalizing/catastrophizing coping strategies.
- These associations were consistent across both nausea assessment methods.
Conclusions:
- Anxiety and specific maladaptive coping strategies are linked to methotrexate-induced nausea in children with JIA.
- Psychological factors may play a crucial role in the inter-individual variability of MTX-related nausea.
- Findings suggest potential targets for interventions to mitigate nausea and improve treatment outcomes in pediatric JIA patients.
Abstract:
The aim of this study is to investigate whether methotrexate-induced nausea is associated with anxiety or the use of coping strategies in children with juvenile idiopathic arthritis (JIA) treated with methotrexate (MTX). This is an observational study of children diagnosed with JIA (ILAR criteria), treated with MTX and aged 9 years or above. MTX-induced nausea was determined by the children's completion of a nausea diary and the parents' completion of the Methotrexate Intolerance Severity Score (MISS). Anxiety was assessed by the Beck Youth Inventories-Anxiety Inventory (BYI-A) and coping strategies were evaluated by an adapted Nausea Coping Questionnaire. Enrolled were 121 children (82 girls: 39 boys) with a median age (IQR) of 13.3 (11.3-15.1) years. The median MTX-dose (IQR) was 9.7 (9.0-10.9) mg/m2/week. The median treatment duration (IQR) was 340 (142-766) days. The MISS was completed for 120 children; 77 children completed the nausea diary for at least 7 days. MTX-induced nausea was present in 61% (73/120) of the children according to the MISS and in 73% (56/77) of the children according to the nausea diary. MTX-induced nausea was associated with a more frequent use of the coping strategy internalizing/catastrophizing (MISS, p = 0.012; diary, p < 0.0001) and higher BYI-A raw scores (diary, p = 0.016). MTX-induced nausea was associated with anxiety and the use of coping strategies in children with JIA. These psychological factors may be part of the mechanism behind the inter-individual variation in the level of nausea to MTX treatment.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Coping Strategies: Emotion Focused

